Page 2 - Software Precertification Pilot Program News Today

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs),...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics , today announced an agreement with SoftBank Corp. to develop... | March 21, 2022

Healthcare

BOSTON--(BUSINESS WIRE)--Jan 18, 2022--

GuruFocus Article or News written by Business Wire and the topic is about:

BOSTON--(BUSINESS WIRE)--Dec 15, 2021--

BOSTON--(BUSINESS WIRE)--Dec 3, 2021--

Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders By Staff 2 seconds ago Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital therapeutics (PDTs) accessible to its members in recovery. Prescryptive Health will offer and administe...

Company adds a leading national Integrated Delivery Network (IDN) as a strategic investor. The financing supports Pear’s continued efforts to expand patient access for its portfolio of Prescription Digital Therapeutics (PDTs), including reSET®, reSET-O® and Somryst® treating addiction and insomnia conditions, respectively. BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced the second closing of its Series D financing. The s...